Publications by authors named "Loubna Bendrioua"

Background: The yeast AMPK/SNF1 pathway is best known for its role in glucose de/repression. When glucose becomes limited, the Snf1 kinase is activated and phosphorylates the transcriptional repressor Mig1, which is then exported from the nucleus. The exact mechanism how the Snf1-Mig1 pathway is regulated is not entirely elucidated.

View Article and Find Full Text PDF

Background/objectives: The SNF1/AMPK protein kinase has a central role in energy homeostasis in eukaryotic cells. It is activated by energy depletion and stimulates processes leading to the production of ATP while it downregulates ATP-consuming processes. The yeast SNF1 complex is best known for its role in glucose derepression.

View Article and Find Full Text PDF

The last decade has seen a rapid development of experimental techniques that allow data collection from individual cells. These techniques have enabled the discovery and characterization of variability within a population of genetically identical cells. Nonlinear mixed effects (NLME) modeling is an established framework for studying variability between individuals in a population, frequently used in pharmacokinetics and pharmacodynamics, but its potential for studies of cell-to-cell variability in molecular cell biology is yet to be exploited.

View Article and Find Full Text PDF

The AMP-activated protein kinase (AMPK) controls energy homeostasis in eukaryotic cells. Here we expressed hetero-trimeric mammalian AMPK complexes in a Saccharomyces cerevisiae mutant lacking all five genes encoding yeast AMPK/SNF1 components. Certain mammalian complexes complemented the growth defect of the yeast mutant on non-fermentable carbon sources.

View Article and Find Full Text PDF

Analysis of the time-dependent behavior of a signaling system can provide insight into its dynamic properties. We employed the nucleocytoplasmic shuttling of the transcriptional repressor Mig1 as readout to characterize Snf1-Mig1 dynamics in single yeast cells. Mig1 binds to promoters of target genes and mediates glucose repression.

View Article and Find Full Text PDF

A number of different viruses including respiratory syncytial virus (RSV) initiate infection of cells by binding to cell surface glycosaminoglycans and sulfated oligo- and polysaccharide mimetics of these receptors exhibit potent antiviral activity in cultured cells. We investigated whether the introduction of different lipophilic groups to the reducing end of sulfated oligosaccharides would modulate their anti-RSV activity. Our results demonstrate that the cholestanol-conjugated tetrasaccharide (PG545) exhibited ∼5- to 16-fold enhanced anti-RSV activity in cultured cells compared with unmodified sulfated oligosaccharides.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers screened 16,671 compounds for their ability to inhibit human respiratory syncytial virus (RSV) using HEp-2 cell cultures, identifying two promising candidates: P13 and C15 with IC₅₀ values of 0.11μM and 0.13μM respectively.
  • Despite their effectiveness in reducing RSV infectivity, P13 and C15 did not exhibit direct virucidal activity or prevent virus attachment, but needed to be present during virus entry and cell-to-cell transmission to inhibit syncytial plaques.
  • Viral variants resistant to these drugs emerged during the experiment, displaying specific amino acid substitutions in the RSV F protein, highlighting the potential for developing effective and selective anti-RSV treatments while understanding the
View Article and Find Full Text PDF